Charity Navigator 4-Star Rating: Six Years of High Honors
We are proud to announce we have been honored with Charity Navigator’s coveted 4-star Charity Navigator rating for the sixth consecutive year! This is the highest rating a charity can receive.
Charity Navigator is the largest and most used charity evaluator in the country. The organization’s recently enhanced rating methodology looks at two broad areas of a charity’s performance: Financial Health and Accountability and Transparency. The new rating system, named CN 2.1, better captures a charity’s long-term capacity and financial health.
It’s an honor to receive this top rating for the sixth year. As a newly merged organization who works hard to ensure your trust, it’s important that we’re held accountable to the highest standard.
Thank you to our Board of Directors, Medical Scientific Advisory Committee and staff for making this accomplishment possible. We also want to give huge thanks to our wonderful community of survivors, caregivers, volunteers and supporters—we couldn’t do this without you. Together, we can knock colon cancer out!
P.S. Want to see more of what we accomplished in the past year with YOUR support? Download our 2015 Annual Report.
Don’t forget, the Colon Cancer Alliance serves as a source of information about colon health. If you have questions or are in need of support, please contact our free Helpline at (877) 422-2030. We’re here to help!
Top resources
Legislation introduced to address young-onset CRC
Explore the urgent need for the Colorectal Cancer Early Detection Act (HR 7714), legislation aimed at combating the rising incidence of colorectal cancer among younger adults through enhanced screening, education, and research.
Dr. John Marshall joins the Alliance as Chief Medical Consultant
A veteran in the field of gastrointestinal cancer research, Dr. Marshall will share his leadership experience and scientific expertise to guide the Alliance’s patient support and research initiatives, particularly Project Cure CRC.
EPIC Act to Advance New CRC Therapies Needs Support
The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.